TSNUp +8.7%Tyson Foods
Why Tyson Foods (TSN) Stock Rose 8.7% Today
Tyson Foods (TSN) rose 8.7% after it reported fiscal fourth quarter results and forecast fiscal 2027 adjusted operating income of $1.7 billion to $2.15 billion.
Movers
Monday
Latest trading day covered
Tyson Foods
Every big move we have covered on Tyson Foods, newest first. Each story gives the answer first and links to the filings and releases behind it.
Last covered move
Close that day$63.95
Figures are from the day of the story, not live quotes.
Why it moved that dayNewest first. Moves and closes are for the day each story covers.
TSNUp +8.7%Tyson Foods
Tyson Foods (TSN) rose 8.7% after it reported fiscal fourth quarter results and forecast fiscal 2027 adjusted operating income of $1.7 billion to $2.15 billion.
SMMT CGON HTHT TSN
Summit Therapeutics fell 16.5% after an FDA Complete Response Letter, and CG Oncology rose 14.0% after trial results. H World and Tyson Foods rose.
TYSON FOODS, INC. filings with the SEC from the last 180 days, newest first. We wrote about 2 of them.
Filings come straight from the SEC's EDGAR database and are listed automatically. They are not written or checked by us. Fetched .
All 26 filings, including insider trade reports. Insider reports filed on the same day are grouped into one row.
Notice of planned insider sale
Form 144Executive or director change
8-KAlso: company update
Insider trade reports (8)
Form 4Annual report
10-KOur story that day
Results announced (earnings release)
8-KInsider trade report
Form 4Company update
8-KCompany update
8-KMajor agreement signed
8-KAlso: new debt or other obligation, company update
Company update
8-KShare offering documents
424B5Major agreement signed
8-KAlso: company update
Company update
8-KShare offering documents
424B5Insider trade report (amended)
4/AQuarterly report
10-QResults announced (earnings release)
8-KInsider trade reports (3)
Form 4New insider ownership report
Form 3Executive or director change
8-KExecutive or director change (amended)
8-K/AShare offering documents
S-3ASRCompany update
8-KExecutive or director change
8-KAlso: company update
Executive or director change
8-KAlso: company update
Showing 19 key filings: company reports, results, annual and quarterly reports, proxies and offerings.
Executive or director change
8-KAlso: company update
Annual report
10-KOur story that day
Results announced (earnings release)
8-KCompany update
8-KCompany update
8-KMajor agreement signed
8-KAlso: new debt or other obligation, company update
Company update
8-KShare offering documents
424B5Major agreement signed
8-KAlso: company update
Company update
8-KShare offering documents
424B5Quarterly report
10-QResults announced (earnings release)
8-KExecutive or director change
8-KExecutive or director change (amended)
8-K/AShare offering documents
S-3ASRCompany update
8-KExecutive or director change
8-KAlso: company update
Executive or director change
8-KAlso: company update
As registered with the SEC
Other stocks in the same day's coverage
Summit Therapeutics
Summit Therapeutics (SMMT) fell 16.5% after it said the FDA issued a Complete Response Letter on its application for ivonescimab in lung cancer.
Close $11.82
CG Oncology
CG Oncology (CGON) rose 14.0% after it said its Phase 3 bladder cancer trial PIVOT-006 met its primary endpoint.
Close $84.78
H World
H World (HTHT) rose 8.9% after the hotel group reported third quarter results and raised its 2026 revenue growth forecast to 9% to 10%.
Close $54.88
These stories explain past price moves using public sources. They are not investment advice. See our disclaimer.